533
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Expanding role of nanotechnology in the management of colorectal cancer

, , &
Pages 157-159 | Published online: 10 Jan 2014

References

  • Coleman M, Ratchet B, Woods LM et al. Trends in socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br. J. Cancer90, 1367–1373 (2004).
  • Manfredi S, Benhamiche A, Meny B, Cheynel N, Rat P, Faivre J. Population-based study of factors influencing occurrence and prognosis of local recurrence after surgery for rectal cancer. Br. J. Surg.88(9), 1221–1227 (2002).
  • Frick GS, Pitari GM, Weinberg DS, Hyslop T, Schulz S, Waldman SA. Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer. Expert Rev. Mol. Diagn.5, 701–713 (2005).
  • Fortina P, Kricka L, Graves D et al. Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer. Trends Biotechnol.25(4), 145–152 (2007).
  • Harisinghani MG, Barentsz J, Hahn PF et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med.348, 2491–2499 (2003).
  • Weissleder R, Tung C, Mahmood U, Bogdanov A Jr. In vivo imaging of tumors with protease activated near-infrared fluorescent probes. Nat. Biotechnol.17, 375–378 (1999).
  • Gao X, Ciu Y, Levenson RM et al.In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol.22, 969–976 (2004).
  • O’Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett.209, 171–176 (2004).
  • Seymour LW, Ferry DR, Anderson D et al. Hepatic drug targeting: Phase I evaluation of polymer-bound doxorubicin. J. Clin. Oncol.20, 1668–1676 (2002).
  • Northfelt DW, Dezube BJ, Thommes JA et al. Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kopasi’s sarcoma after failure of standard chemotherapy. J. Clin. Oncol.15, 653–659 (1997).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.